Literature DB >> 35502113

Noninflammatory thyroid eye disease in Indian subcontinent: Is it a departure from Rundle's curve?

Ayushi Agarwal1, Samreen Khanam1, Shalin Shah1, Akash Raut1.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35502113      PMCID: PMC9333009          DOI: 10.4103/ijo.IJO_2680_21

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   2.969


× No keyword cloud information.
Dear Editor, We commend the sincere efforts of Muralidhar A, Das S, and Tiple S[1] in unearthing new information regarding the clinicodemographic profile of thyroid eye disease (TED) in Indian cohort. The authors wish to put forth their own observations regarding the presentation and epidemiology of TED in the Indian subcontinent. Despite the fact that the natural course of the disease is not fully understood, most of the current literature derives its understanding of the disease from Rundle’s biphasic curve, which describes an initial steep phase of activity followed by a static period of inactive, quiescent disease.[2] Striking differences in disease presentation and demography can be seen between patients from the Indian subcontinent (including our observations and those by Muralidhar et al.[1]) and those documented in western literature [Table 1].
Table 1

Comparison of demographic profile and incidence of noninflammatory disease

ParametersOur Study (n=150)Study by Muralidhar A, and Das S, Tiple S (n=106)Western study[6] (n=152)
Female/Male1.14:11.12:13.34:1
Age (in years) (Mean±SD)38.58±13.3541.30±14.7649±13
Smokers27.33%25.5%40%
LateralityUnilateral44.67%17.9%4%
Thyroid StatusHyperthyroid55.33%46.23%93%
Euthyroid26.67%19.81%3%
Hypothyroid17.33%33.96%4%
Hashimoto Thyroiditis0.67%0%0%
Inactive76%77.4%40%
Active24%22.6%60%
Noninflammatory (no preceding active clinical stage)30.66% (46/150)Not SpecifiedNot Specified
Late presentation of disease activity5.33% (8/150)Not SpecifiedNot Specified
Comparison of demographic profile and incidence of noninflammatory disease Noninflammatory TED, a sparingly reported entity in the west,[3] is a frequent presentation in our clinic and has also been reported as “silent presenter” by Naik and Vasanthapuram.[4] A recent study from the west by Íñiguez-Ariza NM et al.[5] also acknowledges the existence of “Quiet” TED, a subgroup which presents atypically and departs from the Rundle’s curve. These patients do not require corticosteroids during the course of their disease and are more likely to benefit from supportive therapy and surgery, if indicated. Inactive disease, unilateral presentation of TED, proptosis as the initial presenting sign, and orbitopathy with euthyroid status have more commonly been seen by us as well as other investigators from India. Also, delayed onset of disease activity, in patients initially presenting with inactive disease, is a deviation from the biphasic course and mandates identification as a distinct subgroup. The above findings may suggest strong ethnic and genetic influences on the clinical course of the disease and enable us to acknowledge cases that deviate significantly from the clinical picture classically described through the Rundle’s curve. Studies focusing on the population prevalence and clinical course of noninflammatory TED in different ethnic groups of the world are needed. It would also be interesting to re-explore the pathophysiology of TED in this subtype of patients.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  6 in total

1.  Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.

Authors:  Mark F Prummel; Annemieke Bakker; Wilmar M Wiersinga; Lelio Baldeschi; Maarten P Mourits; Pat Kendall-Taylor; Petros Perros; Chris Neoh; A Jane Dickinson; John H Lazarus; Carol M Lane; Armin E Heufelder; George J Kahaly; Suzanne Pitz; Jacques Orgiazzi; Alain Hullo; Aldo Pinchera; Claudio Marcocci; Maria S Sartini; Roberto Rocchi; Marco Nardi; Gerry E Krassas; A Halkias
Journal:  Eur J Endocrinol       Date:  2003-05       Impact factor: 6.664

2.  Rundle and his curve.

Authors:  George B Bartley
Journal:  Arch Ophthalmol       Date:  2011-03

3.  Demographic and clinical profile of 1000 patients with thyroid eye disease presenting to a Tertiary Eye Care Institute in India.

Authors:  Milind N Naik; Varshitha Hemanth Vasanthapuram
Journal:  Int Ophthalmol       Date:  2020-08-25       Impact factor: 2.031

4.  Noninflammatory Thyroid Eye Disease.

Authors:  Shoaib Ugradar; Daniel B Rootman
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2019 Sep/Oct       Impact factor: 1.746

5.  Clinical profile of thyroid eye disease and factors predictive of disease severity.

Authors:  Alankrita Muralidhar; Sima Das; Sweety Tiple
Journal:  Indian J Ophthalmol       Date:  2020-08       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.